Philip M Sedgwick

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Reactive Oxygen Species

Clinical Practice

Top Venues

Acta obstetricia et gynecologica Scandinavica

Journal of clinical medicine

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

This page only lists publications with an associated author ORCID identifier.

Publications

Philip M Sedgwick
Updated guidelines for the reporting of methods and statistical analyses. Acta obstetricia et gynecologica Scandinavica 103 (1) (2024)
Philip M Sedgwick
Updated guidelines for the reporting of methods and statistical analyses. Acta obstetricia et gynecologica Scandinavica 103 (1) (2024)
Philip M Sedgwick
Updated guidelines for the reporting of methods and statistical analyses. Acta obstetricia et gynecologica Scandinavica 103 (1) (2024)
Elizabeth P C Thorne, Constantin M Durnea, Philip M Sedgwick, Stergios K Doumouchtsis
Influence of previous delivery mode on perineal trauma risk. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 159 (3) (2022)
Philip M Sedgwick, Anne Hammer, Ulrik Schiøler Kesmodel, Lars Henning Petersen
Current controversies: Null hypothesis significance testing. Acta obstetricia et gynecologica Scandinavica 101 (6) (2022)
Philip M Sedgwick, Anne Hammer, Ulrik Schiøler Kesmodel, Lars Henning Petersen
When controversies in null hypothesis significance testing prove to be controversial. Acta obstetricia et gynecologica Scandinavica 101 (11) (2022)
Bridget E Bax, Michelle Levene, Murray D Bain, Lynette D Fairbanks, Massimiliano Mirabella, Sema Kalkan Uçar, Thomas Klopstock, Cornelia Kornblum, Hanna Mandel, Shamima Rahman, Agathe Roubertie, Mauro Scarpelli, Philip M Sedgwick, Moshe Baru, Marcia Sellos-Moura, Jeanie Price, Patrick Horn, Niranjanan Nirmalananthan
Erythrocyte Encapsulated Thymidine Phosphorylase for the Treatment of Patients with Mitochondrial Neurogastrointestinal Encephalomyopathy: Study Protocol for a Multi-Centre, Multiple Dose, Open Label Trial. Journal of clinical medicine 8 (8) (2019)